Sua seleção (0)
Detalhe da pesquisa
1.
Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Liver Int;
35(4): 1403-15, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25098386
2.
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Proc Natl Acad Sci U S A;
109(17): 6662-7, 2012 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451913
3.
Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Clin Cancer Res;
16(3): 967-77, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20103676
4.
Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1.
Int J Cancer;
127(4): 859-72, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20013809
5.
Molecular signature linked to acute phase injury and tumor invasiveness in small-for-size liver grafts.
Ann Surg;
251(6): 1154-61, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20485145
6.
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Carcinogenesis;
29(11): 2096-105, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765415
7.
The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation.
Ann Surg;
247(6): 1049-57, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520234
8.
Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
Int J Oncol;
30(2): 375-80, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17203219
9.
FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
Clin Cancer Res;
11(23): 8458-66, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322309
10.
Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma.
Mol Cancer Ther;
4(9): 1430-8, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16170036
11.
Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
World J Gastroenterol;
11(2): 176-81, 2005 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15633211
12.
Imaging of hepatocellular carcinoma patient-derived xenografts using 89Zr-labeled anti-glypican-3 monoclonal antibody.
Biomaterials;
35(25): 6964-71, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836949
13.
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-ß2.
Neoplasia;
13(8): 735-47, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21847365
14.
Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.
PLoS One;
6(4): e18878, 2011 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21533080
15.
The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
PLoS One;
6(11): e27362, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096562
16.
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.
Liver Transpl;
13(12): 1669-77, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18044786
17.
Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
Hepatology;
44(4): 836-43, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17006919
18.
The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation.
Am J Transplant;
5(6): 1264-75, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15888030
19.
FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
Am J Transplant;
5(1): 40-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15636610
20.
Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
Carcinogenesis;
26(3): 681-7, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15604094